BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported fiscal first-quarter earnings of $33 million.

The Boston-based company said it had profit of 72 cents per share. Earnings, adjusted for non-recurring costs and amortization costs, came to $1.14 per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.07 per share.

The provider blood management systems for health care providers and blood collectors posted revenue of $339.4 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $327.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE